
EPR GEO Scorecard: Who Wins the AI Answer, Audited Quarterly
The EPR GEO Scorecard measures Citation Share — how AI engines cite the brands buyers ask about. Five-dimension formula. 750 audits per volume. Quarterly. Auditable.

The EPR GEO Scorecard measures Citation Share — how AI engines cite the brands buyers ask about. Five-dimension formula. 750 audits per volume. Quarterly. Auditable.

Mike Heller, CEO of Talent Resources, on the second volume of the AI Casting Index with 5W AI Communications: the chatbox doesn't count followers — it checks a documented record. MrBeast and Alix Earle cracked the top ten by building one.

Haute Living's Seth Semilof on The AI Luxury 25: when five rival AI engines independently agree on which luxury houses carry authority, the agreement itself is the finding.

Answer engines — ChatGPT, Claude, Gemini, Perplexity, Google AI Overviews — now answer most early-stage buyer research. The pillar on how they decide which brands get cited.

A GEO program without measurement is content marketing with optimism. The five-component scoring formula behind Citation Share — Citation Frequency, Cross-Engine Breadth, Query-Type Breadth, Extractability, Crawl Access.

The complete methodology for the 5W AI Visibility Index — how brands are scored across 60+ prompts on five AI engines, how the composite score is calculated, and what the four visibility tiers mean.

The structural shift is complete. What actually changed, what it means for every brand and communications team, and what the next 18 months look like.

Citation Share is the share of AI-generated answers in which a brand appears. The KPI behind GEO, how it is measured, what it captures, what it does not, and how to set up a Citation Share program.

Microsoft went from a $300B market cap and antitrust hangover in 2014 to over $3 trillion in 2024. The product strategy explains some of it. The communications operation explains the rest — and rebuilt itself across ten distinct disciplines. The working case for full-stack corporate communications.

Novo Nordisk owns the diabetes GLP-1 answer. Eli Lilly owns the weight-loss answer. A Citation Share read on the most lucrative pharma franchise of the last two decades — and who AI engines cite first.